GlassScriptPhysician profile
William T Avara
NPI 1326062969
$24,947.03
in general payments reported to CMS, 2019-2025
17 companies · $72.64 in 2025
The $72.64 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,647 · 2020: $45.18 · 2021: $1,898 · 2022: $543 · 2023: $11K · 2024: $1,865 · 2025: $72.64.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $6,250 · Travel and Lodging: $5,080 · Food and Beverage: $1,485.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $6,250.00 |
| Travel and Lodging | $5,079.52 |
| Food and Beverage | $1,484.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $18,672.33 | 2019-2024 | Davinci Xi, Da Vinci Surgical System |
| Baxter Healthcare | $2,662.83 | 2019-2021 | |
| Medtronic, INC. | $1,851.72 | 2021-2023 | Ligasure, Signia |
| Covidien LP | $754.56 | 2019-2020 | |
| Ethicon US, LLC | $626.35 | 2019-2025 | Vistaseal, Echelon; Endopath, N/A |
| Rhythm Pharmaceuticals, INC. | $73.98 | 2023-2024 | Imcivree, Imcivree |
| Conmed Corporation | $71.43 | 2024 | Airseal |
| Davol INC. | $32.35 | 2022 | |
| Novo Nordisk INC | $31.91 | 2022-2023 | Wegovy |
| Teleflex LLC | $28.90 | 2023 | Titan Sgs Standard Gastric Stapler |
| Nevro Corp. | $24.29 | 2019 | |
| Mallinckrodt Enterprises LLC | $24.01 | 2019 | |
| Mallinckrodt Hospital Products INC. | $21.05 | 2021 | |
| Csl Behring | $18.59 | 2020 | |
| Smith+Nephew, INC. | $18.55 | 2024 | Pico 14, Renasys Touch |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $17.11 | 2024 | Zepbound |
| Merck Sharp & Dohme LLC | $17.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Avara listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.